A pilot study of topiramate dosages for migraine prophylaxis in an Asian population

The Journal of Headache and Pain

Brief Report

S. Fook-Chong¹  S. Y. Lum²  H. C. Siow²  Y. L. Lo² 

[1] Department of Clinical Research, Singapore General Hospital, Singapore, Singapore;Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Outram Road, 169608, Singapore, Singapore;

关键词: Migraine;    Prophylaxis;    Topiramate;    Asian;    Dose;    Trial;   

DOI  :  10.1007/s10194-010-0193-4

 received in 2009-09-23, accepted in 2010-01-18,  发布年份 2010

来源: Springer

【 摘 要 】

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.

【 授权许可】

Unknown   
© Springer-Verlag 2010